Daiichi Kasei Sangyo Co.,Ltd.

Daiichi Kasei Sangyo Co., Ltd., a Japan-based for-profit international organization, supplies industrial gases and cryogenic liquids to the U.S. Department of Defense as a prime contractor across four active indefinite delivery vehicles and approximately 1,199 delivery orders, all awarded without set-aside designation. The vendor competes on full-and-open basis, reflecting the specialized and limited-source nature of its product portfolio and its established single-source supplier status for precision-grade cryogenic materials to defense agencies operating in the Asia-Pacific region.

Daiichi Kasei Sangyo's capability footprint is narrowly specialized: liquid nitrogen, liquid argon, liquid oxygen, aviator's breathing oxygen, technical-grade nitrogen, dewar equipment, and cylinder re-certification services. These products support naval operations, medical facilities, aviation programs, and research activities at U.S. military installations, predominantly in Japan. Representative recent delivery orders include a $4,584.69 order from the Defense Logistics Agency Energy (April 2025) for aviator's breathing oxygen; a $26,001.47 order from Naval Sea Systems Command (December 2025) for liquid argon at a naval pier; and a $16,013.74 order from NAVSEA (April 2024) for liquid argon to government storage tanks. The vendor also recently established a five-year IDV with the Department of Energy (awarded April 1, 2026, ceiling $1,260,355.26) for liquid nitrogen and aviator's breathing oxygen delivery at Middle East locations through September 2031.

Customer concentration is heavily skewed toward the Department of the Navy: Naval Supply Systems Command leads with 374 awards ($15.1 million combined potential value), followed by the Bureau of Medicine and Surgery (272 awards, $5.4 million), Naval Sea Systems Command (218 awards, $2.6 million), and the Defense Logistics Agency Energy (247 awards, $7 million). These four accounts represent 88% of the vendor's $36.6 million combined potential value across all awards. Navy medical and supply operations dominate the portfolio; NAICS concentration is sharp—1,132 of 1,199 awards fall under Industrial Gas Manufacturing (325120), with a secondary cluster of 68 medical and surgical supply awards.

Daiichi Kasei Sangyo holds multiple active indefinite delivery vehicles. The Defense Health Agency Blanket Purchase Agreement (awarded September 1, 2025, ceiling $1.9 million through August 31, 2030) authorizes supply of medical and industrial gases including liquid oxygen, liquid nitrogen, liquid argon, technical-grade nitrogen, aviator's breathing oxygen, and cylinder re-certification services. Naval Sea Systems Command's October 16, 2025 IDV (ceiling $234,073.60 through September 30, 2027) covers liquid nitrogen, liquid argon, and dewar equipment. A Defense Logistics Agency Energy IDV provides aviator's breathing oxygen, liquid nitrogen, and technical-grade nitrogen. The top parent vehicle, IDC SPE60121D1512 (Defense Logistics Agency Energy), carried 145 task orders totaling $272 thousand; IDC N6264907A0088 (NAVSEA) generated 136 task orders ($1.5 million). These vehicles enable routine, rapid-turnaround procurement of consumable gases with individual delivery order values typically ranging from several hundred to a few thousand dollars and completion within days to weeks.

Activity has grown from 49 awards in 2022 to a peak of 92 in 2024, moderating slightly to 77 in 2025. Recent monthly activity remains steady, with six delivery orders in April 2026 alone. The vendor holds no subcontract work and maintains no identified teaming relationships; 100% of its awards are prime contracts. All awards carry firm fixed-price delivery order terms, no set-asides, and place of performance in Japan or, in the new Middle East IDV, at forward locations. Daiichi Kasei Sangyo has been registered in the System for Award Management since December 2004, establishing it as an established, single-source supplier for specialized cryogenic materials critical to U.S. defense readiness in the Pacific theater and now expanding into the Middle East.